Tofacitinib citrate 540737-29-9 Rheumatoid Arthritis Anticancer
Isanwo:T/T, L/C
Ipilẹṣẹ ọja:China
Ibudo Gbigbe:Beijing/Shanghai/Hangzhou
Agbara iṣelọpọ:100kg / osù
Bere fun (MOQ):25kg
Akoko asiwaju:3 Awọn ọjọ iṣẹ
Ipo ipamọ:Ti fipamọ ni itura, ibi gbigbẹ, iwọn otutu yara.
Ohun elo idii:ilu
Iwọn idii:25kg/ilu
Alaye aabo:Ko lewu de
Ọrọ Iṣaaju
Tofacitinib, jẹ oogun ti a lo lati ṣe itọju arthritis rheumatoid, arthritis psoriatic, ati ulcerative colitis.
Tofacitinib citrate ni a lo lati tọju awọn agbalagba pẹlu niwọntunwọnsi si arthritis rheumatoid ti nṣiṣe lọwọ pupọ ti wọn ti ni esi ti ko pe si, tabi ti ko ni ifarada, methotrexate.
Tofacitinib citrate jẹ itọkasi fun itọju iwọntunwọnsi si àìdá lọwọ rheumatoid arthritis (RA) ninu awọn agbalagba ti ko dahun ni deede si, tabi ti ko ni ifarada si ọkan tabi diẹ sii ti n ṣatunṣe awọn oogun antirheumatic ti arun.
Ni pato (ni ile)
| Nkan | Sipesifikesonu |
| Ifarahan | Funfun tabi pa-funfun okuta lulú |
| Idanimọ | IR, HPLC |
| Omi | ≤1.5% |
| Awọn nkan ti o jọmọ | TOFA 06 ≤0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib dehydrogenated ≤0.15% | |
| Aimọ aimọ kọọkan ≤0.10% | |
| Lapapọ Awọn idoti: ≤1.0% | |
| Awọn ohun elo ti o ku | Ethanol ≤5000ppm |
| Benzene ≤2ppm | |
| Toluene ≤890ppm | |
| Chlroroethane ≤1000ppm | |
| N, N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| eeru sulfate | ≤0.1% |
| Eru Irin | ≤10ppm |
| Chrial HPLC | 3S, 4S tofacitinib ≤0.15% |
| Ayẹwo (lori ipilẹ anhydrous) 98.0-102.0% |
